Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q15825

Entry ID Method Resolution Chain Position Source
AF-Q15825-F1 Predicted AlphaFoldDB

423 variants for Q15825

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1292521572
CA371106834
4 S>G No ClinGen
gnomAD
rs970878049
CA176020270
4 S>I No ClinGen
TOPMed
CA371106804
rs1178800692
6 G>E No ClinGen
TOPMed
CA371106790
rs1189031065
7 Q>P No ClinGen
gnomAD
CA371106766
rs1248313490
8 G>V No ClinGen
TOPMed
rs1213154571
CA371106729
11 H>Q No ClinGen
gnomAD
rs754696130
CA4734492
11 H>R No ClinGen
ExAC
TOPMed
gnomAD
rs751417062
CA4734491
12 G>R No ClinGen
ExAC
gnomAD
CA4734490
rs200229186
15 C>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA176020260
rs202025303
15 C>Y No ClinGen
TOPMed
gnomAD
CA176020258
rs1012412400
16 L>F No ClinGen
TOPMed
gnomAD
CA176020254
rs952380979
17 W>* No ClinGen
TOPMed
CA371106611
rs1232173139
17 W>* No ClinGen
gnomAD
rs150939999
CA4734489
17 W>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1563627945
CA371106571
19 C>W No ClinGen
Ensembl
CA176020250
rs200023923
19 C>Y No ClinGen
Ensembl
CA4734487
rs202231701
20 V>M No ClinGen
Ensembl
rs1210920131
CA371106523
21 F>S No ClinGen
Ensembl
CA371106479
rs1298967345
23 P>L No ClinGen
gnomAD
rs141199708
CA4734486
26 K>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371106420
rs1437779731
26 K>T No ClinGen
gnomAD
rs199661937
CA4734470
27 G>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371108408
rs1265938441
29 V>A No ClinGen
TOPMed
CA4734469
COSM1201127
rs779903018
32 A>V large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
COSM1489308
rs1424156589
CA371108372
34 E>K Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA176056840
rs199915060
36 R>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs199915060
RCV000909206
CA4734468
36 R>T No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs750356194
CA4734467
37 L>P No ClinGen
ExAC
rs1053179817
CA176056830
38 F>L No ClinGen
TOPMed
rs1485439517
CA371108303
40 K>N No ClinGen
gnomAD
CA371108309
rs1186115768
40 K>R No ClinGen
gnomAD
CA176056820
rs938862644
41 L>R No ClinGen
Ensembl
CA371108277
rs1207304276
42 F>L No ClinGen
gnomAD
rs140930963
CA4734466
43 S>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA4734465
rs201193166
44 H>L No ClinGen
ExAC
TOPMed
gnomAD
CA176056793
rs201193166
44 H>R No ClinGen
ExAC
TOPMed
gnomAD
rs1246033398
CA371108246
45 Y>D No ClinGen
gnomAD
CA4734464
rs80342906
46 N>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4734463
rs577392421
49 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA371108155
rs969485351
51 P>A No ClinGen
gnomAD
CA176056776
rs969485351
51 P>T No ClinGen
gnomAD
CA371108136
rs1181599970
52 V>G No ClinGen
TOPMed
rs1563626942
CA371108143
52 V>M No ClinGen
Ensembl
rs143970583
CA4734459
55 V>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs149966755
CA4734457
57 D>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1458311976
CA371108050
58 P>S No ClinGen
gnomAD
CA4734454
rs201222770
60 T>M No ClinGen
ExAC
gnomAD
rs747611447
CA4734455
60 T>P No ClinGen
ExAC
TOPMed
gnomAD
CA371107975
rs1294856478
63 F>S No ClinGen
gnomAD
rs1184151318
CA371107958
64 E>G No ClinGen
gnomAD
CA4734452
rs746661270
65 V>A No ClinGen
ExAC
gnomAD
CA4734453
rs139682260
65 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1210978974
CA371107935
66 A>T No ClinGen
gnomAD
CA4734451
rs199896509
66 A>V No ClinGen
ExAC
gnomAD
rs758160316
CA371107923
67 I>F No ClinGen
ExAC
gnomAD
CA4734450
rs758160316
67 I>L No ClinGen
ExAC
gnomAD
CA371107904
rs1333773919
68 T>I No ClinGen
gnomAD
CA371107907
rs1213455048
68 T>S No ClinGen
gnomAD
rs778775487
CA4734448
69 Q>K No ClinGen
ExAC
gnomAD
rs1586428843
CA371107855
72 N>H No ClinGen
Ensembl
CA176056656
rs1039700407
72 N>S No ClinGen
TOPMed
gnomAD
CA4734444
rs375802894
73 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA371106250
rs1436635001
75 E>D No ClinGen
gnomAD
rs1173291808
CA371106253
75 E>G No ClinGen
gnomAD
rs1384520170
CA371106256
75 E>Q No ClinGen
gnomAD
rs1393846803
CA371106246
76 V>G No ClinGen
gnomAD
rs947747542
CA176053067
80 M>T No ClinGen
gnomAD
CA4734427
rs199556613
80 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA371106195
rs1476995036
83 N>S No ClinGen
TOPMed
CA581628851
rs1191400306
84 L>* No ClinGen
TOPMed
gnomAD
rs751636774
CA4734425
84 L>V No ClinGen
ExAC
gnomAD
rs1444995364
CA371106179
85 W>* No ClinGen
gnomAD
TCGA novel 86 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4734423
COSM3432444
rs201337765
87 R>C large_intestine [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs750749188
CA4734422
87 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs201337765
CA4734424
87 R>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4734421
rs765710849
88 H>R No ClinGen
ExAC
gnomAD
rs1486350968
CA371106166
88 H>Y No ClinGen
gnomAD
rs1193895968
CA371105912
89 I>T No ClinGen
gnomAD
CA371105915
rs1275000948
89 I>V No ClinGen
gnomAD
CA176051755
rs771793966
90 W>C No ClinGen
Ensembl
rs199635862
CA176051751
91 N>K No ClinGen
Ensembl
rs146332801
CA4734399
92 D>E No ClinGen
ESP
ExAC
TOPMed
rs924570495
CA176051750
92 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs745521586
CA4734398
96 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA4734396
rs188620180
96 R>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs188620180
CA4734397
96 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 97 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4734395
rs202156793
97 W>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 98 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1411620647
CA371105837
100 M>K No ClinGen
TOPMed
rs76092830
CA4734394
100 M>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs200380236
CA4734393
101 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA176051700
rs202058490
104 G>D No ClinGen
TOPMed
rs202058490
CA176051699
104 G>V No ClinGen
TOPMed
CA176051693
rs201382342
105 I>T No ClinGen
TOPMed
COSM3663767
CA4734391
rs762757187
105 I>V liver [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA4734390
rs772909612
106 E>* No ClinGen
ExAC
gnomAD
CA371105799
rs772909612
106 E>K No ClinGen
ExAC
gnomAD
CA176051675
rs199882168
107 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA4734389
rs376053270
108 L>F No ClinGen
ESP
ExAC
gnomAD
rs748108347
CA4734388
109 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs892284569
COSM1100070
CA176051666
109 R>H Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA4734386
rs200852535
110 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs74376609
CA4734387
110 V>I No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 112 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4734385
rs141518931
COSM1100069
112 A>V Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs779230403
CA4734384
113 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs907337035
CA176051652
113 D>N No ClinGen
TOPMed
gnomAD
TCGA novel 113 D>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4734383
rs757453851
116 W>* No ClinGen
ExAC
gnomAD
CA4734382
rs754167856
119 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA371105696
rs1375663880
122 L>P No ClinGen
gnomAD
rs1277790168
CA371105690
123 Y>C No ClinGen
gnomAD
rs200592176
CA176051615
COSM750309
124 N>D lung Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
rs749461734
CA4734364
125 N>K No ClinGen
ExAC
gnomAD
CA4734381
rs199650282
125 N>T No ClinGen
ExAC
gnomAD
rs756407019
CA4734363
127 V>F No ClinGen
ExAC
TOPMed
gnomAD
CA4734362
rs756407019
127 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs748564975
CA4734361
130 F>S No ClinGen
ExAC
gnomAD
rs748564975
CA371105634
130 F>Y No ClinGen
ExAC
gnomAD
CA371105618
rs1156389056
132 V>G No ClinGen
gnomAD
CA4734360
rs781631069
133 E>K No ClinGen
ExAC
gnomAD
rs755513435
CA371105606
134 G>D No ClinGen
ExAC
gnomAD
rs755513435
CA4734359
134 G>V No ClinGen
ExAC
gnomAD
CA371105586
rs1586424678
137 K>R No ClinGen
Ensembl
rs1175476217
CA371105575
139 L>I No ClinGen
gnomAD
TCGA novel 140 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4734356
rs201720371
143 N>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371105545
rs1392438389
143 N>S No ClinGen
Ensembl
rs1186881316
CA371105541
144 G>S No ClinGen
gnomAD
CA371105527
rs1274168912
145 M>I No ClinGen
TOPMed
CA371105532
rs1240549357
145 M>T No ClinGen
gnomAD
CA371105516
rs1381221205
147 T>N No ClinGen
gnomAD
CA176051483
rs919417562
148 W>* No ClinGen
TOPMed
rs1287244765
CA371105511
148 W>G No ClinGen
TOPMed
gnomAD
rs764989489
CA4734354
149 T>P No ClinGen
ExAC
gnomAD
rs1486057766
CA371105495
150 P>L No ClinGen
gnomAD
CA4734353
rs761650753
151 P>S No ClinGen
ExAC
gnomAD
CA371105488
rs776597137
152 A>S No ClinGen
ExAC
gnomAD
CA4734352
rs776597137
152 A>T No ClinGen
ExAC
gnomAD
rs35592906 155 K>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4734351
rs764054092
155 K>N No ClinGen
ExAC
gnomAD
rs1586424632
CA371105462
156 S>R No ClinGen
Ensembl
CA4734350
rs373147726
156 S>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4734349
rs775552140
157 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA371105452
rs775552140
157 S>Y No ClinGen
ExAC
gnomAD
rs773288237
CA4734346
158 C>S No ClinGen
ExAC
gnomAD
rs1017343652
CA176051443
159 P>L No ClinGen
TOPMed
gnomAD
rs1375547876
CA371105443
159 P>S No ClinGen
gnomAD
rs202201450
CA176051436
160 M>L No ClinGen
Ensembl
CA371105434
rs1563624127
160 M>T No ClinGen
Ensembl
CA176051419
rs1007830583
163 T>N No ClinGen
Ensembl
rs781543564
CA4734342
164 F>L No ClinGen
ExAC
gnomAD
rs892949999
CA176051375
165 F>S No ClinGen
Ensembl
rs774808608 165 F>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs866356960
CA176051354
168 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs747459603
CA4734339
170 Q>* No ClinGen
ExAC
gnomAD
rs1384963245
CA371105361
170 Q>H No ClinGen
TOPMed
gnomAD
rs79945499
CA4734338
171 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs1186167138
CA371105355
171 N>S No ClinGen
gnomAD
CA4734336
rs749970855
172 C>F No ClinGen
ExAC
gnomAD
rs757816015
CA4734337
172 C>R No ClinGen
ExAC
gnomAD
rs777615925
CA371105342
173 S>C No ClinGen
gnomAD
CA176051303
rs777615925
173 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1563624088
CA371105335
175 K>E No ClinGen
Ensembl
rs201127531
CA4734334
177 G>D No ClinGen
ExAC
gnomAD
rs1401153332
CA371105310
178 S>F No ClinGen
TOPMed
rs753627072
CA4734333
179 W>R No ClinGen
ExAC
TOPMed
gnomAD
COSM1569044
rs200478711
CA4734332
180 T>M Variant assessed as Somatic; 4.624e-05 impact. oesophagus large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs200745568
CA4734330
184 A>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1184329212
CA371105262
185 E>D No ClinGen
gnomAD
rs267601934
CA176051215
185 E>K No ClinGen
Ensembl
rs767534563
CA4734329
186 I>T No ClinGen
ExAC
rs1412357303
CA371105258
186 I>V No ClinGen
gnomAD
rs1563624058
CA371105249
187 D>V No ClinGen
Ensembl
CA176051201
rs199955670
191 I>T No ClinGen
Ensembl
CA4734324
rs545769727
193 S>* No ClinGen
1000Genomes
ExAC
gnomAD
CA4734325
rs762037634
193 S>T No ClinGen
ExAC
TOPMed
gnomAD
rs201856103
CA176051174
194 K>T No ClinGen
Ensembl
rs1348850134
CA371105186
197 M>K No ClinGen
TOPMed
CA371105182
rs1185963813
198 N>H No ClinGen
gnomAD
rs372469952
CA371105173
199 D>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs372469952
CA4734321
199 D>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs772665574
CA4734320
202 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs143385261
CA4734319
203 N>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA176051156
rs199627128
205 E>A No ClinGen
TOPMed
CA581928887
rs1274627299
206 W>* No ClinGen
gnomAD
TCGA novel 206 W>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs56315032
CA4734317
207 E>* No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1563624009
CA371105109
207 E>G No ClinGen
Ensembl
CA176051143
rs910018042
208 I>N Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs753533097
CA4734316
209 I>T No ClinGen
ExAC
gnomAD
rs1187376268
CA371105048
216 H>L No ClinGen
TOPMed
rs200667694
CA176051117
218 I>F No ClinGen
Ensembl
TCGA novel 219 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 220 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1393071489
CA371105021
220 Y>N No ClinGen
gnomAD
CA371105011
rs1371088716
221 N>Y No ClinGen
gnomAD
rs1330494992
CA371105004
222 C>R No ClinGen
gnomAD
rs1441340377
CA371104998
222 C>W No ClinGen
gnomAD
rs1397011499
CA371104985
224 E>G No ClinGen
gnomAD
CA4734311
rs199987912
226 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1455197127
CA371104965
227 Y>H No ClinGen
TOPMed
rs368839862
CA4734310
228 T>A No ClinGen
ESP
ExAC
gnomAD
TCGA novel 228 T>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs574697613
CA4734309
228 T>R No ClinGen
1000Genomes
ExAC
gnomAD
CA4734308
rs761949537
229 D>E No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 229 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4734307
rs776803911
230 I>L No ClinGen
ExAC
gnomAD
CA176051068
rs776803911
230 I>V No ClinGen
ExAC
gnomAD
CA4734306
rs373761304
231 T>I No ClinGen
ESP
ExAC
rs1250400989
CA371104932
232 Y>* No ClinGen
gnomAD
CA4734305
rs369966241
233 S>C No ClinGen
1000Genomes
ESP
ExAC
gnomAD
rs369966241
CA4734304
233 S>F No ClinGen
1000Genomes
ESP
ExAC
gnomAD
rs746371215
CA4734302
236 I>M No ClinGen
ExAC
gnomAD
CA4734303
rs534708905
236 I>T No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 238 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs200497100
CA4734301
240 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA371104881
rs200497100
240 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA371104875
rs1315108119
241 M>T No ClinGen
gnomAD
rs199671238
CA4734298
243 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4734299
rs199671238
243 Y>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4734297
rs138339131
244 T>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA4734296
rs138339131
244 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs754789848
CA4734294
246 N>T No ClinGen
ExAC
gnomAD
CA4734293
rs751495876
250 P>H No ClinGen
ExAC
TOPMed
gnomAD
CA176051011
rs751495876
250 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs200987418
CA176051019
250 P>S No ClinGen
gnomAD
rs1290756717
CA371104811
251 C>F No ClinGen
gnomAD
rs1392196914
CA371104797
253 F>C No ClinGen
Ensembl
CA4734292
rs766345085
255 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA371104782
rs1379724177
256 F>L No ClinGen
gnomAD
TCGA novel 257 L>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs41265264
CA4734289
259 V>A No ClinGen
1000Genomes
ExAC
gnomAD
CA371104761
rs41265264
259 V>E No ClinGen
1000Genomes
ExAC
gnomAD
rs373928428
CA371104762
259 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs373928428
CA4734290
259 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4734288
rs760963856
260 L>S No ClinGen
ExAC
gnomAD
CA4734287
rs775630227
263 Y>H No ClinGen
ExAC
TOPMed
gnomAD
CA371104731
rs1261969063
264 L>V No ClinGen
gnomAD
CA176050962
rs201796500
265 P>A No ClinGen
Ensembl
COSM1100063
rs201295503
CA4734286
266 S>L endometrium Variant assessed as Somatic; 4.62e-05 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
rs774973747
COSM454595
CA4734284
267 D>Y Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
TCGA novel 272 V>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371104678
rs771583412
272 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs771583412
CA4734283
272 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA4734281
rs144350308
273 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4734279
rs747826040
277 S>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1423765299
CA371104641
278 V>F No ClinGen
gnomAD
rs1359993781
CA371104634
279 L>P No ClinGen
gnomAD
CA4734277
rs780776442
282 L>P No ClinGen
ExAC
gnomAD
rs1352342531
CA371104615
283 T>A No ClinGen
Ensembl
CA371104608
rs1374160038
284 V>L No ClinGen
gnomAD
CA371104595
rs1323564212
286 L>V No ClinGen
TOPMed
rs373608967
CA176050874
288 V>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
NCI-TCGA
TOPMed
gnomAD
rs544312612
CA176050844
289 I>F No ClinGen
TOPMed
rs544312612
CA176050853
289 I>V No ClinGen
TOPMed
CA176050836
rs894446733
291 E>G No ClinGen
Ensembl
TCGA novel 294 P>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs763093183
CA176050814
295 S>F No ClinGen
gnomAD
rs200072442
CA176050803
296 T>A No ClinGen
TOPMed
gnomAD
rs753856041
CA4734271
296 T>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA176050807
rs200072442
296 T>S No ClinGen
TOPMed
gnomAD
CA4734270
COSM256624
rs371233399
297 S>Y large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
gnomAD
TCGA novel 299 V>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs142629147
CA4734269
300 V>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs142629147
CA371104514
300 V>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1271655539
CA371104518
300 V>L No ClinGen
gnomAD
rs760634963
CA176050769
304 G>C No ClinGen
Ensembl
CA176050764
rs199921540
304 G>V No ClinGen
Ensembl
rs1416675138
CA371104486
CA371104487
305 E>D No ClinGen
TOPMed
gnomAD
rs1294417545
CA4734265
305 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
TCGA novel 307 L>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4734263
rs201852908
307 L>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA371104471
rs1264415609
308 L>Q No ClinGen
TOPMed
rs773917226
CA4734260
310 T>P No ClinGen
ExAC
TOPMed
gnomAD
CA176050732
rs200829161
311 M>L No ClinGen
gnomAD
rs989145751
CA4734258
312 I>M No ClinGen
TOPMed
rs35812517
CA176050722
314 V>G No ClinGen
Ensembl
rs1318474382
CA371104428
315 T>P No ClinGen
TOPMed
gnomAD
CA4734257
rs769343905
317 S>T No ClinGen
ExAC
gnomAD
rs888527245
CA176050712
318 I>T No ClinGen
gnomAD
rs1164010419
CA371104412
318 I>V No ClinGen
TOPMed
TCGA novel 319 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs200331504
CA4734256
319 V>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1475918111
CA371104394
321 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1235188547
CA371104385
322 V>A No ClinGen
gnomAD
rs1310032653
CA371104389
322 V>M No ClinGen
TOPMed
rs776324742
CA4734255
323 F>L No ClinGen
ExAC
gnomAD
CA4734254
rs185610062
325 L>F No ClinGen
1000Genomes
ExAC
gnomAD
rs376849555
CA371104355
327 I>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371104351
rs1586424093
327 I>M No ClinGen
Ensembl
rs1196511863
CA371104352
327 I>T No ClinGen
TOPMed
gnomAD
rs376849555
CA4734253
327 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4734252
rs779838446
328 H>Y No ClinGen
ExAC
gnomAD
rs758246174
CA371104340
329 Y>C No ClinGen
ExAC
gnomAD
CA4734251
rs758246174
329 Y>F No ClinGen
ExAC
gnomAD
CA176050657
rs745799927
330 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs982008922
CA176050652
330 R>H No ClinGen
TOPMed
gnomAD
CA4734250
rs745799927
330 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs976951248
CA176050639
331 T>I No ClinGen
TOPMed
gnomAD
CA4734249
rs778753253
332 P>L No ClinGen
ExAC
gnomAD
rs201530242
CA4734248
333 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA4734247
rs200513077
334 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs199691486
CA4734245
336 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 336 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4734242
rs763481468
338 P>L No ClinGen
ExAC
gnomAD
CA371104283
rs1410996394
339 R>T No ClinGen
gnomAD
CA371104279
rs1181169424
340 W>R No ClinGen
TOPMed
rs201193214
CA176050602
342 K>R No ClinGen
TOPMed
gnomAD
rs1234510279
CA371104253
343 T>R No ClinGen
gnomAD
rs1176587004
CA371104248
344 V>D No ClinGen
gnomAD
CA371104233
rs1253344186
346 L>R No ClinGen
TOPMed
gnomAD
rs372377533
CA4734241
349 L>P No ClinGen
ESP
ExAC
CA371104213
rs1215806027
350 P>S No ClinGen
gnomAD
rs148473463
CA4734240
351 Q>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371104197
rs1586424023
352 V>G No ClinGen
Ensembl
CA371104191
rs1307749459
354 L>M No ClinGen
TOPMed
gnomAD
rs146758501
CA4734237
355 M>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4734236
rs760306390
356 R>K No ClinGen
ExAC
TOPMed
gnomAD
rs775188873
CA4734235
357 W>C No ClinGen
ExAC
gnomAD
rs1015162630
CA176050573
CA371104147
360 D>E No ClinGen
TOPMed
gnomAD
rs1322359932
CA371104128
363 R>M No ClinGen
gnomAD
TCGA novel 364 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371104125
rs1400751721
364 G>S No ClinGen
gnomAD
CA4734234
rs771821259
365 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA4734233
rs745708157
368 D>E No ClinGen
ExAC
gnomAD
rs778858240
CA4734232
369 A>T No ClinGen
ExAC
gnomAD
CA176050557
rs200235440
371 P>L No ClinGen
Ensembl
CA4734230
rs148005281
371 P>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1199067757
CA371104073
373 G>S No ClinGen
gnomAD
CA371104067
rs781148492
374 L>F No ClinGen
ExAC
gnomAD
CA4734229
rs781148492
374 L>V No ClinGen
ExAC
gnomAD
rs755171508
CA4734228
375 A>S No ClinGen
ExAC
gnomAD
rs967179925
CA176050550
375 A>V No ClinGen
Ensembl
rs751829318
CA4734227
376 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs202064963
CA176050524
377 R>K No ClinGen
gnomAD
rs1363994011
CA371104041
378 P>L No ClinGen
TOPMed
rs780465151
CA4734226
379 A>P No ClinGen
ExAC
gnomAD
CA4734225
rs758816455
384 A>G No ClinGen
ExAC
gnomAD
CA371104001
rs1306159308
385 S>G No ClinGen
gnomAD
CA371103996
rs1217810067
385 S>R No ClinGen
gnomAD
CA176050515
rs1024240469
386 H>R No ClinGen
gnomAD
CA371103981
rs1248203431
388 E>K No ClinGen
TOPMed
gnomAD
CA371103969
rs765736119
389 P>L No ClinGen
ExAC
gnomAD
rs765736119
CA4734223
389 P>R No ClinGen
ExAC
gnomAD
rs762239006
CA4734222
391 H>R No ClinGen
ExAC
gnomAD
TCGA novel 391 H>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371103959
rs1197760281
391 H>Y No ClinGen
TOPMed
gnomAD
rs754425823
CA4734221
392 L>F No ClinGen
ExAC
gnomAD
CA371103939
rs1261203616
394 E>* No ClinGen
TOPMed
CA371103937
rs1419094680
394 E>A No ClinGen
TOPMed
gnomAD
CA371103936
rs1419094680
394 E>V No ClinGen
TOPMed
gnomAD
CA4734220
rs375308043
396 F>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs775098974
CA4734218
397 H>R No ClinGen
ExAC
gnomAD
CA4734219
rs760216470
397 H>Y No ClinGen
ExAC
gnomAD
TCGA novel 399 H>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1187339289
CA371103904
399 H>Y No ClinGen
gnomAD
CA371103895
rs1476473678
400 K>E No ClinGen
gnomAD
CA176050487
rs894469999
401 S>* No ClinGen
Ensembl
CA4734217
rs199981801
402 N>H No ClinGen
ExAC
gnomAD
rs1486312222
CA371103875
403 E>K No ClinGen
gnomAD
rs1050651669
CA176050475
405 A>V No ClinGen
TOPMed
gnomAD
CA4734214
rs770847142
406 T>A No ClinGen
ExAC
gnomAD
rs144179003
CA4734213
408 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1194462672
CA371103787
415 P>L No ClinGen
TOPMed
CA176050438
rs201030441
418 W>* No ClinGen
Ensembl
rs139568359
COSM274544
CA4734211
423 S>L Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4734209
rs554811242
425 H>R No ClinGen
1000Genomes
ExAC
gnomAD
CA371103720
rs1563623571
425 H>Y No ClinGen
Ensembl
CA4734207
rs144573255
426 S>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1356059742
CA371103713
426 S>P No ClinGen
gnomAD
CA4734208
rs144573255
426 S>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4734205
rs200703945
429 V>A No ClinGen
ExAC
gnomAD
rs757706465
CA4734204
431 D>Y No ClinGen
ExAC
gnomAD
CA176050399
rs934971009
432 V>A No ClinGen
TOPMed
rs146330757
CA4734202
437 Q>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4734201
rs755568911
439 I>V No ClinGen
ExAC
gnomAD
CA371103607
rs1309062249
442 N>D No ClinGen
gnomAD
CA4734200
rs752232974
COSM3834754
443 M>I Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA176050384
rs572202252
443 M>T No ClinGen
1000Genomes
TOPMed
CA176050378
rs199530109
444 K>R No ClinGen
Ensembl
CA371103570
rs1365096692
447 N>H No ClinGen
TOPMed
rs16891583
CA371103566
447 N>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs16891583
VAR_048171
CA4734199
447 N>S No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA176050368
rs901323193
450 K>Q No ClinGen
Ensembl
CA4734198
rs201566938
450 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1243967511
CA371103408
452 V>L No ClinGen
TOPMed
CA371103400
rs1457448977
453 E>G No ClinGen
TOPMed
gnomAD
rs556036982
CA4734176
453 E>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs773174628
CA4734175
454 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs1586422411
CA371103375
456 W>* No ClinGen
Ensembl
CA581627832
COSM2961999
rs1563622765
458 Y>* lung [Cosmic] No ClinGen
cosmic curated
Ensembl
CA371103356
rs1371918246
459 V>M No ClinGen
TOPMed
CA371103348
rs1194653333
460 A>T No ClinGen
gnomAD
CA371103344
rs1268997182
461 M>V No ClinGen
TOPMed
gnomAD
CA176048833
rs1022227052
463 V>A No ClinGen
TOPMed
CA371103327
rs1441737282
463 V>M No ClinGen
gnomAD
CA176048830
rs776544169
466 V>A No ClinGen
TOPMed
rs1487891734
CA371103296
468 L>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs746006983
CA4734169
472 I>M No ClinGen
ExAC
gnomAD
rs771212852
CA4734167
473 I>M No ClinGen
ExAC
gnomAD
rs774385978
CA4734168
473 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA371103245
rs1202235066
475 C>F No ClinGen
TOPMed
gnomAD
CA4734166
rs55662044
476 V>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA4734165
rs778121297
477 F>S No ClinGen
ExAC
gnomAD
rs868428586
CA176048808
478 G>E No ClinGen
Ensembl
rs770198289
CA4734164
479 T>A No ClinGen
ExAC
gnomAD
CA176048806
rs202141415
479 T>S No ClinGen
Ensembl
CA4734163
rs748652876
482 L>I No ClinGen
ExAC
TOPMed
rs1300106249
CA371103204
483 F>L No ClinGen
gnomAD
CA4734161
rs201034972
484 L>P No ClinGen
ExAC
gnomAD
CA176048795
rs150660043
485 Q>* No ClinGen
ESP
TOPMed
gnomAD
TCGA novel 486 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1432179844
CA371103171
488 L>P No ClinGen
gnomAD
rs371523970
CA176048788
489 G>R No ClinGen
ESP
CA4734156
rs750186865
490 N>D No ClinGen
ExAC
gnomAD
rs761738595
CA4734154
491 T>P No ClinGen
ExAC
gnomAD
TCGA novel 493 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA176048759
rs200851744
493 K>R No ClinGen
gnomAD
CA371103143
rs200851744
493 K>T No ClinGen
gnomAD
CA4734152
rs764113730
494 S>P No ClinGen
ExAC
gnomAD

No associated diseases with Q15825

3 regional properties for Q15825

Type Name Position InterPro Accession
domain FKBP-type peptidyl-prolyl cis-trans isomerase domain 165 - 251 IPR001179
domain Trigger factor, C-terminal 270 - 425 IPR008880
domain Trigger factor, ribosome-binding, bacterial 1 - 149 IPR008881

Functions

Description
EC Number
Subcellular Localization
  • Postsynaptic cell membrane; Multi-pass membrane protein
  • Cell membrane; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
acetylcholine-gated channel complex A homo- or hetero-pentameric protein complex that forms a transmembrane channel through which ions may pass in response to acetylcholine binding.
anchoring junction A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix.
dopaminergic synapse A synapse that uses dopamine as a neurotransmitter.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of postsynaptic membrane The component of the postsynaptic membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of presynaptic membrane The component of the presynaptic membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
neuron projection A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
synapse The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.

5 GO annotations of molecular function

Name Definition
acetylcholine receptor activity Combining with an acetylcholine receptor ligand and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
acetylcholine-gated cation-selective channel activity Selectively enables the transmembrane transfer of a cation by a channel that opens upon binding acetylcholine.
excitatory extracellular ligand-gated ion channel activity Enables the transmembrane transfer of an ion by a channel that opens when a specific extracellular ligand has been bound by the channel complex or one of its constituent parts, where channel opening contributes to an increase in membrane potential.
neurotransmitter receptor activity Combining with a neurotransmitter and transmitting the signal to initiate a change in cell activity.
transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential Any transmitter-gated ion channel activity that is involved in regulation of postsynaptic membrane potential.

8 GO annotations of biological process

Name Definition
chemical synaptic transmission The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
ion transmembrane transport A process in which an ion is transported across a membrane.
membrane depolarization The process in which membrane potential decreases with respect to its steady-state potential, usually from negative potential to a more positive potential. For example, the initial depolarization during the rising phase of an action potential is in the direction from the negative steady-state resting potential towards the positive membrane potential that will be the peak of the action potential.
nervous system process A organ system process carried out by any of the organs or tissues of neurological system.
regulation of dopamine secretion Any process that modulates the frequency, rate or extent of the regulated release of dopamine.
regulation of membrane potential Any process that modulates the establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
regulation of synaptic vesicle exocytosis Any process that modulates the frequency, rate or extent of synaptic vesicle exocytosis.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

37 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q07263 CHRNA3 Neuronal acetylcholine receptor subunit alpha-3 Bos taurus (Bovine) PR
P04758 CHRNB1 Acetylcholine receptor subunit beta Bos taurus (Bovine) PR
Q8SPU7 CHRNA5 Neuronal acetylcholine receptor subunit alpha-5 Bos taurus (Bovine) PR
P09481 CHRNA3 Neuronal acetylcholine receptor subunit alpha-3 Gallus gallus (Chicken) PR
P26152 CHRNA5 Neuronal acetylcholine receptor subunit alpha-5 Gallus gallus (Chicken) PR
Q9I8C7 CHRNA10 Neuronal acetylcholine receptor subunit alpha-10 Gallus gallus (Chicken) PR
P43679 CHRNB3 Neuronal acetylcholine receptor subunit beta-3 Gallus gallus (Chicken) PR
Q5IS75 CHRNB3 Neuronal acetylcholine receptor subunit beta-3 Pan troglodytes (Chimpanzee) PR
Q5IS76 CHRNA6 Neuronal acetylcholine receptor subunit alpha-6 Pan troglodytes (Chimpanzee) PR
P25162 nAChRbeta2 Acetylcholine receptor subunit beta-like 2 Drosophila melanogaster (Fruit fly) PR
P14867 GABRA1 Gamma-aminobutyric acid receptor subunit alpha-1 Homo sapiens (Human) PR
O14764 GABRD Gamma-aminobutyric acid receptor subunit delta Homo sapiens (Human) PR
Q9UN88 GABRQ Gamma-aminobutyric acid receptor subunit theta Homo sapiens (Human) PR
P11230 CHRNB1 Acetylcholine receptor subunit beta Homo sapiens (Human) PR
Q05901 CHRNB3 Neuronal acetylcholine receptor subunit beta-3 Homo sapiens (Human) PR
P30532 CHRNA5 Neuronal acetylcholine receptor subunit alpha-5 Homo sapiens (Human) PR
P32297 CHRNA3 Neuronal acetylcholine receptor subunit alpha-3 Homo sapiens (Human) PR
P48167 GLRB Glycine receptor subunit beta Homo sapiens (Human) PR
P23415 GLRA1 Glycine receptor subunit alpha-1 Homo sapiens (Human) PR
O75311 GLRA3 Glycine receptor subunit alpha-3 Homo sapiens (Human) PR
P23979 Htr3a 5-hydroxytryptamine receptor 3A Mus musculus (Mouse) PR
P04756 Chrna1 Acetylcholine receptor subunit alpha Mus musculus (Mouse) PR
P09690 Chrnb1 Acetylcholine receptor subunit beta Mus musculus (Mouse) PR
Q8BMN3 Chrnb3 Neuronal acetylcholine receptor subunit beta-3 Mus musculus (Mouse) PR
Q2MKA5 Chrna5 Neuronal acetylcholine receptor subunit alpha-5 Mus musculus (Mouse) PR
Q9R0W9 Chrna6 Neuronal acetylcholine receptor subunit alpha-6 Mus musculus (Mouse) PR
P43144 Chrna9 Neuronal acetylcholine receptor subunit alpha-9 Rattus norvegicus (Rat) PR
P35563 Htr3a 5-hydroxytryptamine receptor 3A Rattus norvegicus (Rat) PR
P12391 Chrnb3 Neuronal acetylcholine receptor subunit beta-3 Rattus norvegicus (Rat) PR
P04757 Chrna3 Neuronal acetylcholine receptor subunit alpha-3 Rattus norvegicus (Rat) PR
P25109 Chrnb1 Acetylcholine receptor subunit beta Rattus norvegicus (Rat) PR
P25108 Chrna1 Acetylcholine receptor subunit alpha Rattus norvegicus (Rat) PR
P20420 Chrna5 Neuronal acetylcholine receptor subunit alpha-5 Rattus norvegicus (Rat) PR
P43143 Chrna6 Neuronal acetylcholine receptor subunit alpha-6 Rattus norvegicus (Rat) PR
P54244 deg-3 Acetylcholine receptor subunit alpha-type deg-3 Caenorhabditis elegans PR
P54246 acr-5 Acetylcholine receptor subunit alpha-type acr-5 Caenorhabditis elegans PR
Q93149 acr-3 Acetylcholine receptor subunit beta-type acr-3 Caenorhabditis elegans PR
10 20 30 40 50 60
MLTSKGQGFL HGGLCLWLCV FTPFFKGCVG CATEERLFHK LFSHYNQFIR PVENVSDPVT
70 80 90 100 110 120
VHFEVAITQL ANVDEVNQIM ETNLWLRHIW NDYKLRWDPM EYDGIETLRV PADKIWKPDI
130 140 150 160 170 180
VLYNNAVGDF QVEGKTKALL KYNGMITWTP PAIFKSSCPM DITFFPFDHQ NCSLKFGSWT
190 200 210 220 230 240
YDKAEIDLLI IGSKVDMNDF WENSEWEIID ASGYKHDIKY NCCEEIYTDI TYSFYIRRLP
250 260 270 280 290 300
MFYTINLIIP CLFISFLTVL VFYLPSDCGE KVTLCISVLL SLTVFLLVIT ETIPSTSLVV
310 320 330 340 350 360
PLVGEYLLFT MIFVTLSIVV TVFVLNIHYR TPTTHTMPRW VKTVFLKLLP QVLLMRWPLD
370 380 390 400 410 420
KTRGTGSDAV PRGLARRPAK GKLASHGEPR HLKECFHCHK SNELATSKRR LSHQPLQWVV
430 440 450 460 470 480
ENSEHSPEVE DVINSVQFIA ENMKSHNETK EVEDDWKYVA MVVDRVFLWV FIIVCVFGTA
490
GLFLQPLLGN TGKS